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Schiff base 2-(1-(2-(piperazin-1-yl)ethylimino)ethyl)phenol and its complexes of Mn(II), Ni(II) and Zn(II)  were 
synthesized and characterized by molar conductance,  FTIR, NMR, UV-Visible and elemental analysis. The 
complexes showed 1:1 metal to ligand (M:L) ratio according to the result obtained from Job’s method analysis. 
Elemental analysis and IR spectral data are in good agreement with the proposed structure of the ligand and the 
complexes. Both the ligand and its complexes were screened for in-vitro antibacterial activity against two gram 
negative (Escherichia coli and Klebsella) and two gram positive (Staphylococcus aureus and Streptococcus 
pyrogenes) bacterial strains. The result of antibacterial activity showed that both the ligand and its complexes 
have activity more than the referenced drug and that the complexes are more active than free ligand. 
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INTRODUCTION 
Piperazine derivatives have wide range of 
biological activities viz antihilmentics (Khyrul 
Islam et al., 2006), antimicrobial (Narendra et al., 
2006), antipsychotic (Alka et al., 2010), anti-PAF, 
anti-HIV (Wafa et al, 2006), anti-cancer (Can-
Cheng et al, 2004), anti-obesity (Ming et al, 2010), 
for the treatment of Alzeimer’s disease (Sadashiva 
et al, 2006), potent MC4-receptor (Dai et al, 2007), 
drug designer with serotnergic properties (Roland 
et al, 2004), potent dopamine uptake inhibitors 
(Makoto et al, 2004), etc. Piperazine derivatives of 
1-(2-aminoethyl)piperazine were evaluated for 
antibacterial activities in this study. Of the various 
classes of Schiff bases obtained from the 
condensation of amines and carbonyl compounds, 
there is little or no report on the biological 
activities of this amine (Narendra et al, 2006). 
Despite their ability to form very interesting 
ligands due to their good bridging ability, 
piperazine derivatives were also found to have 
antibacterial activity. 
Such wide spectrum of biological 
applications of piperazine compounds aroused our 
research interest to synthesize novel Schiff base 
derived from condensation of 1-(2-
aminoethyl)piperazine and 2-hydroxyacetophenone 
and its transition metal complexes. The study also 
evaluate the antimicrobial activities of the Schiff  
base and its  Mn(II), Ni(II) and Zn(II).  
 
 
MATERIALS AND METHODS 
Materials  
The percentages of C, H and N were 
obtained from Perkin elmer CHNS-932 elemental 
analyzer. The 
1
H-NMR spectra were recorded from 
ECA-400 high performance FT-NMR 
spectrophotometer (with SiMe4 as standard). 
Infrared spectra in the region of 4000-400cm
-1
 were 
obtained from KBr-pellets with a Perkin elmer PE-
1600 FT-IR spectrometer. Thermogravimetric 
measurements were obtained from Perkin elmer 
TG4000 thermoanalyzer while the UV-visible 
spectra were recorded on Perkin Elmer PC-650 
UV-visible spectrophotometer. The 1-(2-
aminoethyl) piperazine, 1-(2-hydroxyphenyl) 
ethanone, solvents (ethanol, methanol and DMSO-
d6) and the metal salts used were of analytical 
grade, purchased from Sigma-Aldrich company 
and used without further purifications. 
 
Synthesis of the ligand: 
To a stirred ethanolic solution of 1-(2-
aminoethyl)piperazine (0.13g, 10mmol) was added 
drop-wise to the equimolar quantity ethanolic 
solution of  1-(2-hydroxyphenyl) ethanone (0.14g, 
10mmol) at room temperature and then refluxed for 
2hrs at 60
0
C, the solution was cooled down and the 
solvent evaporated using rotary evaporator to give 
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Synthesis of the complexes:  
To the methanolic solution of the Schiff 
base ligand (0.25g, 10mmol) an equimolar 
methanolic solution of ZnCl2 (0.14g, 10mmol) was 
added with stirring at room temperature. Pale 
yellow solution was formed which after stirring for 
2 minutes generates a white precipitate, the 
precipitate was filtered, washed with ethanol and 
dried in the vacuum. The precipitate was washed 
with water-ethanol mixture (50:50) and dried in the 
vacuum. Same procedure was followed for the 
preparation of Mn(II) and Ni(II) complexes (Salga 
et al, 2013). Yield: (Mn: 0.24g, 64.5%), (Ni: 0.29g, 
77.3%), (Zn: 0.27g,70%). Anal.Calcd:  
 
 
C14H20Cl2MnN3O: C, 45.1; H, 5.4; N, 19.1. Found: 
C, 39.8; H, 4.4; N, 16.8. C14H20Cl2N3NiO: calcd: C, 
44.7; H, 5.4; N, 11.2. Found: C, 41; H, 4.8; N, 9.6. 
C14H20Cl2N3OZn: calcd: C, 43.9; H, 5.3; N, 10.98. 


















C) (no charge). Job 











). NMR (DMSO-d6): 
NH, 2.0ppm; C=N, 1.81ppm; phenyl ring, 7.02; O-
H, 13.19ppm (ligand only). Uv-visible (DMSO): 
λmax for L, Mn, Ni and Zn, (262, 285,277, 
267nm). 
Scheme 1: Reaction pathway for the synthesis of ligand and the complex 
Antimicrobial study 
The compounds were assayed for 
antimicrobial activity by well-diffusion method 
(Iffet et al, 2004). Each compound was dissolved in 
DMSO at concentration of (100μl) 1mg/mL and 
placed in the respective wells. Other wells were 
supplemented with DMSO and referenced 
antibacterial drug, amoxicillin served as negative 
and positive controls, respectively. 1cm
3





 was placed in 
sterile Petri dishes. Molten nutrient agar (15cm
3
) 
maintained at ca 45
o
C was poured into the Petri 
dishes and allowed to solidify. Holes of 6mm were 
formed in the agar and filled with the test solutions. 
The plates were incubated for 24h at 36
o
C. The 
tests were carried out in triplicate. Growth 
inhibition was compared with the standard drug. In 
order to clarify any participating role of DMSO in 
screening activity of the compounds, separate 
studies were carried out with DMSO alone and no 
activity was found against any of the bacterial 
strains.  




Results and Discussion 
The infrared spectra of the Schiff base and 
its complexes shows prominent absorptions at 
3388, 3417, 3404 and 3494cm
-1
 respectively which 
can be attributed to  secondary amines of the 
piperazine ring changing from (R2NH) cyclohexane  
 
 
form in the free ligand to (R2NH2
+
) chair 
conformations in the complexes, at 1609, 1593, 
1606, 1584cm
-1 
regions ν(C=N) was observed 
which shows some shifts from 1609cm
-1
 in the 
ligand spectra down to 1584cm
-1
 in the spectra of 
the complexes indicating complexation of the metal 
ions with the Schiff base.  
 
 
Figure 1: FTIR spectra for the ligand and its complexes 
Stretching mode of C-O/phenolate for the 
ligand and its complexes were observed at 1494, 
1372, 1241, 1267cm
-1 
which further confirmed the 
participation of phenol group in the ligand in 
bonding with the metal ion by shifting from 
1494cm
-1
 in the ligand down to 1241cm
-1
 in the 
spectra of the complexes (Mukhopadhyay et al, 
2003) (Figure 1) as proposed in the scheme of the 
reaction. NMR spectra of all the complexes shows 
same signal being derived from same Schiff base.  
     
Figure 2: 
1
H-NMR spectra for the ligand and its complexes 




The chemical shifts at 2.0ppm, 1.81ppm 
and 7.02ppm can be assignable to N-H, C=N, and  
 
 
phenyl ring respectively as appeared in the proton 
nmr spectra of both the Schiff base and its Zn 
complex as manifested in Table 2 and Figure 2.  
 
Figure 3: UV-VIS spectra 
 
Figure 4: Determination of Metal-ligand ratio using Job’s Method 
Signal at 13.19ppm representing OH was 
only observed in the ligand spectra which is absent 
in the spectra of the complexes, this indicate its 
participation in bonding (Fig. 2). However, Mn, 
and Ni complexes did not show clear spectra in the 
proton nmr. UV-visible spectra shows 
bathochromic shifts of maximum wavelength from 
262nm in the Schiff base to 285nm, 277nm and 
267nm in Mn, Ni and Zn complexes respectively, 
which can be attributed to ligand-metal charge 
transfer (Pavia et al, 1996) in the bonding sites 
(Fig. 3). Elemental analysis shows values of C, H 
and N to be in good agreement with the calculated 
values and the complex was stoichiometrically 
found to be 1:1 (M:L), from the result of Job’s 
method analysis (Fig. 4) with no charge outside the 
coordination sphere as revealed by the conductivity 
measurements in DMSO at various temperatures. 
 












Ligand 3394 1609 753 
Mn-complex - 1593 760 
Ni- complex - 1606 756 




H-NMR result for the ligand and its complexes of Mn(II), Ni(II) and Zn(II) 
Ligand/Complex NH (ppm) -C=N- (ppm) 
Ligand 2.05 3.65 
Zn- complex 2.18 3.50 
13
C-NMR   
Ligand 14.80 46.50 
Zn- complex 19.13 28.10 
 
The Schiff base 2-(1-(2-(piperazin-1-
yl)ethylimino)ethyl)phenol  and its complexes of  
Mn(II), Ni(II) and Zn(II) were analyzed in vitro for 
their ability to inhibit the growth of representative 
gram positive(Staphylococcus aureus and 
Streptococcus pyrogenes) and gram negative 
(Escherichia coli and Klebsiella pneumonia) 
bacteria. The susceptibilities of certain strains of 
bacteria to the Schiff base and its complexes were 
evaluated by measuring the size of bacteriostatic 
diameter as shown in Table 3. 
 
Table 3: Results for the Antimicrobial Activity of the Ligand and its Complexes 
Ligands/Complex S. Aureus (mm) S. pyrogenes (mm)  E. Coli (mm) K. Pneumonia (mm) 
Ligand 18 14 18 20 
Mn-complex 08 05 07 09 
Ni- complex 19 08 04 07 
Zn- complex 09 15 10 10 
Amoxicillin 00 00 14 15 
 
According to literature report (Koksal et 
al, 2001), the Schiff bases were found to show 
more activity than their corresponding complexes 
under identical condition. 
In conclusion, similar observation was 
made in our previous study (Salga et al, 2013). 
However, in this work, the Schiff base shows more 
activity on Klebsiella pneumonia with the nickel 
complex showing the highest activity on 
staphylococcus while zinc complex shows highest 
activity on streptococcus. Manganese complex was 
found to be active on all the bacterial strains but 
does not show highest activity in any case. The 
control drug was found to be completely inactive 
against the gram positive bacteria as shown in table 
3. This manifested the resistant behavior of the 
bacterial strains (used for this study) to the 
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